NEW YORK (GenomeWeb News) – The Inova Translational Medicine Institute and GNS Healthcare today announced a deal to develop and commercialize computer models based on GNS' technology.

The models will be built using GNS' Reverse Engineering and Forward Simulation data analysis platform, next-generation sequencing, and electronic medical record data that can predict preterm live birth risk, Inova and GNS said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.